Search Tag: Accelerate Diagnostics

ICU Management

Sepsis code implementation at Vall d’Hebron University Hospital: rapid diagnostics key to success

2017 22 Nov

Implementation of a sepsis code, Código Sepsis, in October 2015 at the Vall d’Hebron University Hospital in Barcelona has led to better detection and a significant reduction in mortality. The hospital is the largest in Barcelona, with more than 1,100 beds and 7,000 employees.The objectives of Código Sepsis are to increase suspicion of sepsis and septic... Read more

ICU Management

Accelerate Diagnostics welcomes Dr. Romney Humphries as Chief Scientific Officer

2017 15 Sep

Accelerate Diagnostics, Inc. has announced the addition of Romney Humphries, PhD, D(ABMM), M(ASCP) to its executive management team as Chief Scientific Officer. Dr. Romney Humphries comes to Accelerate from UCLA Medical Center where she was the Section Chief for Clinical Microbiology and the Assistant Clinical Professor of the Department of Pathology... Read more

ICU Management

Accelerate Diagnostics Announces Sizeable Release of Data at ASM Microbe 2017

2017 30 May

Accelerate Diagnostics, Inc. has announced that new data from 11 healthcare institutions covering more than 1,200 samples will be presented at the upcoming annual meeting of the American Society for Microbiology – ASM Microbe in New Orleans, LA.The data comes from external studies that evaluated the potential clinical and workflow benefits of the Accelerate... Read more

ICU Management

Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering

2017 15 May

Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its common stock, upsized from the original share offering of 2,500,000 shares of common stock, at a previously disclosed public offering price of $28.85 per share. The gross proceeds to Accelerate Diagnostics... Read more

ICU Management

Accelerate Diagnostics Reports 191 Instruments Under Contract & 3x Revenue Growth

2017 03 May

Accelerate Diagnostics, Inc. has announced preliminary financial results for the quarter ending March 31, 2017 including signed customer evaluation contracts covering 169 instruments, 22 additional instruments converted into revenue generating placements, and revenue growth exceeding 325% of the same period in the prior year.Net sales for the first... Read more